EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case Report

Ibrahim El-Serafi, Rui He, Ying Zhao, Jonas Mattsson, Moustapha Hassan

Clinical Drug Investigation · 2026-09 · 46 (9) · 1031-1036

DOI: 10.1007/s40261-026-01581-9 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Drug Investigation, online erschienen am 10.07.2026. Verfasst von Ibrahim El-Serafi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet-Huddinge, 141 86, NovumStockholm, Sweden. Hauptthemen laut MEDLINE: Omeprazole, Hematopoietic Stem Cell Transplantation, Busulfan, Transplantation Conditioning. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Karolinska Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OmeprazoleHematopoietic Stem Cell TransplantationBusulfanTransplantation ConditioningProton Pump InhibitorsHumansDrug InteractionsMaleLeukemia, Myeloid, AcuteFemaleCytochrome P-450 CYP2C19Middle AgedAdult

Substanzen

OmeprazoleBusulfanCytochrome P-450 CYP2C19CYP2C19 protein, humanProton Pump Inhibitors

Autor:innen und Institutionen

  • Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet-Huddinge, 141 86, NovumStockholm, Sweden.
  • Basic Medical Sciences Department, College of Medicine, Ajman University, Ajman, UAE.
  • Department of Human Resource, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
  • Clinical Research Center and Center of Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Huddinge, Sweden.
  • Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada.
  • Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Förderung

  • Karolinska Institute

Zitieren

APA

El-Serafi, I., He, R., Zhao, Y., Mattsson, J., & Hassan, M. (2026). Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case Report. Clinical Drug Investigation, 46(9), 1031-1036. https://doi.org/10.1007/s40261-026-01581-9

Vancouver

El-Serafi I, He R, Zhao Y, Mattsson J, Hassan M. Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case Report. Clinical Drug Investigation. 2026;46(9):1031-1036. doi:10.1007/s40261-026-01581-9

BibTeX
@article{ElSerafi2026,
  author = {El-Serafi, Ibrahim and He, Rui and Zhao, Ying and Mattsson, Jonas and Hassan, Moustapha},
  title = {Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case Report},
  journal = {Clinical Drug Investigation},
  year = {2026},
  volume = {46},
  number = {9},
  pages = {1031--1036},
  doi = {10.1007/s40261-026-01581-9}
}
Kostenlos starten →